The Feasibility and Efficacy of a Two-week MCT Treatment of Anxiety Disorders in a Group Setting
试验速览
- 阶段
- 不适用
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Generalized Anxiety Disorder-7 (Change)
研究概览
简要总结
Long treatment durations may not always be feasible for patients due to pressure to get better quickly, long travel distance to treatment clinics, inflexible working hours, or childcare. To overcome these challenges intensive treatments are currently emerging and several research studies have shown significant and lasting results of diagnosis-specific intensive treatments. A transdiagnostic treatment in a group setting can contribute to a more efficient course of treatment for patients.
Research suggests that Metacognitive Therapy (MCT) is an effective treatment for anxiety disorders. However, MCT has not previously been used on inpatients over a two-week period. To make the treatment tangible for patients and easy to administer for therapists over a short time, attention training technique (ATT) will mainly be used as a changing technique.
The main aim of the study is to explore the feasibility and efficacy of intensive and short-term MCT for anxiety disorders in a group setting.
详细描述
Design: The study will use randomized control trial with a waitlist control. Cohorts of 12 included patients will be randomly assigned to active treatment or waitlist for two weeks. The waitlist patients will receive the same treatment immediately after the two-week waiting period.
Inclusion criteria: Adults ranging from 18 to 30 years of age meeting diagnostic criteria for generalised anxiety disorder, social phobia, and/or panic disorder with or without agoraphobia will be included in the study. Further the participants must be able to communicate in Norwegian and provide written consent.
Exclusion criteria: Exclusion criteria will be ongoing drug abuse, history of psychotic episodes, current suicidality, or participants not able to adapt to an intensive group format.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 30 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults between 18 and 30 years
- •Meeting diagnostic criteria for generalised anxiety disorder, social phobia, and/or panic disorder with or without agoraphobia
- •Provide written consent to partake in the study
排除标准
- •Ongoing drug abuse
- •History of psychotic episodes
- •Current suicidality
- •Participants not able to adapt to an intensive group format
结局指标
主要结局
Generalized Anxiety Disorder-7 (Change)
时间窗: Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.
The Generalized Anxiety Disorder-7 (GAD-7, Spitzer et al., 2006) will be used to measure anxiety symptoms. GAD-7 is a seven-item, self-report measure which assess the severity of anxiety symptoms within the last two weeks. The items are scored on a four-point Likert scale (0-3), with the scores ranging from minimum 0 to maximum 21. Higher scores means worse outcome.
次要结局
- Metacognition questionnaire 30 (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- Patient Health Questionnaire-9 (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- Work ability score (WAS) (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- Social Phobia Inventory (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- CAS-1 (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- Inventory of Interpersonal Problems (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
- The Short Warwick-Edinburgh Mental Well-Being scale (Change)(Change from baseline; pre-intervention; after the intervention; 3 months follow up; 6 months follow up.)
研究者
Sverre Urnes Johnson
Associate Professor Sverre Urnes Johnson
University of Oslo
